Table 3.
Health Care Providers’ Knowledge and Attitude about RTD
Knowledge and Attitude | N | % |
---|---|---|
Prior to survey, have you heard of RTD | ||
Yes | 31 | (34.1) |
No | 60 | (65.9) |
Missing/Unknown/No response | 0 | (0.0) |
Rate your general knowledge of RTD | ||
None/limited | 71 | (78.0) |
Somewhat/knowledgeable | 20 | (22.0) |
Missing/Unknown/No response | 0 | (0.0) |
Ethical or religious concerns about discussing RTD with a patient | ||
Yes | 4 | (4.4) |
No | 87 | (95.6) |
Missing/Unknown/No response | 0 | (0.0) |
Comfortable discussing RTD with cancer patients | ||
Yes | 36 | (40.0) |
No | 16 | (17.8) |
Not sure | 38 | (42.2) |
Missing/Unknown/No response | 1 | |
Comfortable discussing RTD with a patient you are seeing for the first time | ||
Yes | 8 | (8.8) |
No | 53 | (58.2) |
Not sure | 30 | (32.9) |
Missing/Unknown/No response | 0 | (0.0) |
Is your decision to discuss RTD with a patient influenced by your current knowledge of the topic | ||
Yes | 51 | (56.0) |
No | 15 | (16.5) |
Not sure | 24 | (26.4) |
Missing/Unknown/No response | 1 | (1.1) |
Worries about RTD | ||
Emotional state of the patient following introduction of this topic | 65 | (71.4) |
Ethical and legal issues related to informed consent | 6 | (6.6) |
Ethical and legal issues related to the storage of human biological samples of deceased individuals | 2 | (2.2) |
That the technologies can easily be used for the wrong purposes | 3 | (3.3) |
Missing/Unknown/No response | 15 | (16.5) |
Benefits about RTD | ||
Provides larger tumor samples | 13 | (14.3) |
Allows sampling of multiple tumor sites (heterogeneity) | 23 | (25.3) |
Allows testing on later stage or aggressive cancers (Stage III–IV) | 10 | (11.0) |
Ability to reveal or confirm newer therapies/methods | 23 | (25.3) |
Obtaining fresh tissue | 15 | (16.5) |
Missing/Unknown/No response | 7 | (7.7) |